Skip to main content

A pilot study of active immunotherapy with CEA (6D) VRP vaccine (AVX701) in patients with stage III colon cancer.

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

AlphaVax, Inc.

Start Date

October 1, 2013

End Date

September 1, 2021
 

Administered By

Duke Cancer Institute

Awarded By

AlphaVax, Inc.

Start Date

October 1, 2013

End Date

September 1, 2021